Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29544371 | 0.88 | EGFR (0.41) | EGFR | |
| SCHEMBL29544774 | 0.86 | EGFR (0.40) | EGFR | |
| SCHEMBL29544730 | 0.86 | EGFR (0.42) | EGFRBUB1 | |
| SCHEMBL29544972 | 0.84 | EGFR (0.37) | EGFR | |
| SCHEMBL29544599 | 0.84 | EGFR (0.36) | EGFR | |
| SCHEMBL29544819 | 0.83 | EGFR (0.37) | EGFR | |
| SCHEMBL29544554 | 0.82 | BRD4 (0.38) | EGFRBUB1 | |
| SCHEMBL29544491 | 0.82 | BUB1 (0.38) | EGFRBUB1 | |
| SCHEMBL29544538 | 0.81 | BRD4 (0.40) | EGFR | |
| SCHEMBL29544438 | 0.80 | TYK2 (0.36) | EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022072634-A1 | BICYCLIC COMPOUNDS FOR USE IN THE TREATMENT CANCER | SCORPION THERAPEUTICS, INC. (US) | 2022-04-07 | — | — | WO | disclosed |